Design, Synthesis and Evaluation of Peroxisome Proliferator-Activated Receptor α/βDual Agonists for the Treatment of Type 2 Diabetes

Saibal Kumar Das; Chandrasekhar Abbineni; Krovvidi Venkata Lakshmi Narasimha Rao; Javed Iqbal; Ravi Krishna Babu; Ranjan Chakrabarti

doi:10.2174/157018007778992883

ISSN: 1570-1808
E-ISSN: 1875-628X

Design, Synthesis and Evaluation of Peroxisome Proliferator-Activated Receptor α/βDual Agonists for the Treatment of Type 2 Diabetes
Authors: Saibal Kumar Das¹, Chandrasekhar Abbineni², Krovvidi Venkata Lakshmi Narasimha Rao³, Javed Iqbal⁴, Ravi Krishna Babu⁵ and Ranjan Chakrabarti⁶
View Affiliations Hide Affiliations

¹ Metabolic Disorders Group,Discovery Research, Dr. Reddy's Laboratories Ltd, Bollaram Road,Miyapur, Hyderabad 500 049, AP, India. ² Metabolic Disorders Group,Discovery Research, Dr. Reddy's Laboratories Ltd, Bollaram Road,Miyapur, Hyderabad 500 049, AP, India. ³ Metabolic Disorders Group,Discovery Research, Dr. Reddy's Laboratories Ltd, Bollaram Road,Miyapur, Hyderabad 500 049, AP, India. ⁴ Metabolic Disorders Group,Discovery Research, Dr. Reddy's Laboratories Ltd, Bollaram Road,Miyapur, Hyderabad 500 049, AP, India. ⁵ Metabolic Disorders Group,Discovery Research, Dr. Reddy's Laboratories Ltd, Bollaram Road,Miyapur, Hyderabad 500 049, AP, India. ⁶ Metabolic Disorders Group,Discovery Research, Dr. Reddy's Laboratories Ltd, Bollaram Road,Miyapur, Hyderabad 500 049, AP, India.
Source: Letters in Drug Design & Discovery, Volume 4, Issue 1, Jan 2007, p. 27 - 32
DOI: https://doi.org/10.2174/157018007778992883
- Available online: 01 Jan 2007

Abstract

The design, synthesis and evaluation of several dual PPARα/γ agonists with three different heterocycles, viz. pyrazolo[4,3-d]pyrimidin-7-one, quinazolin-4-one and benzo[e][1,3]oxazine-4-one for the treatment of type 2 diabetes and associated dyslipidemia are described. Among them, compound 5cb was found to possess a potent dual PPARα/β agonist property. It significantly reversed diabetic hyperglycemia while improving overall lipid homeostasis in preclinical animal models.

Article metrics loading...

/content/journals/lddd/10.2174/157018007778992883

2007-01-01

2025-06-11

From This Site

/content/journals/lddd/10.2174/157018007778992883

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Full text loading...

/content/journals/lddd/10.2174/157018007778992883

Article Type: Research Article

Keyword(s): Diabetes; Dyslipidemia and Plasma glucose; Ethyl 3-(4-aminophenyl)-2-ethoxypropionate; PPAR; Synthesis

Design, Synthesis and Evaluation of Peroxisome Proliferator-Activated Receptor α/βDual Agonists for the Treatment of Type 2 Diabetes

Abstract

From This Site

Most Read This Month

Most Cited Most Cited RSS feed

Discovery, Structural Determination and Anticancer Activities of Lactucinlike Guaianolides

Thermodynamic Aspects of Cancer: Possible Role of Negative Entropy in Tumor Growth, its Relation to Kinetic and Genetic Resistance

Immunomodulatory Properties of Synthetic Imidazolone Derivatives

Design and Prediction of ADME/Tox Properties of Novel Magnolol Derivatives as Anticancer Agents for NSCLC Using 3D-QSAR, Molecular Docking, MOLCAD and MM-GBSA Studies

Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease

Identifying Protein Binding Sites and Optimal Ligands

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides

Selection of a Catalytically Active Enzyme In Vivo Via Phage Display of its Product

A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development